CHEK2 and breast cancer: Patients carrying the CHEK2 c.1100delC variant were diagnosed with a first primary invasive BC at a younger age (median age 52 years in carriers compared to 56 years in non‐carriers) and in earlier calendar years (36.4% of carriers was diagnosed before 2000, compared to 27.6% of the non‐carriers).